Best Peptide Companies, Ranked by Purity Documentation
A look at how research peptide suppliers document purity, from batch-specific COAs to generic percentage claims, and what separates the two in practice.
Reviewed by Benjamin Clark, MD, internal medicine physician ·
Benjamin Clark, MD is a board-certified internal medicine physician with clinical and academic training in evidence-based pharmacotherapy at Vanderbilt University Medical Center.
- coa
- purity
- suppliers
- research-peptides
Ranking the best peptide companies for research by purity documentation means looking past the percentage printed on a product page and asking where that number came from, whether it is tied to the specific batch being sold, and whether an independent lab produced it. A supplier can advertise “99% pure” on every listing without ever publishing a certificate that a buyer can check against the vial in hand. This guide ranks suppliers on documentation practice rather than price or marketing copy, using only what each company states publicly about its own testing.
What Purity Documentation Actually Means
A certificate of analysis, or COA, is a lab report that lists the specific tests run on a sample and the results. For research peptides, a useful COA identifies the compound, states a purity percentage from a named analytical method such as HPLC, and is tied to a batch or lot number that matches the vial or bag it accompanies. That last detail is what separates documentation from decoration. A COA with no batch number could belong to any run the supplier ever produced, including one that has nothing to do with the product currently listed.
Purity documentation also includes who ran the test. A result generated in-house, on equipment the supplier owns and controls, is not the same as a result from an independent third-party lab with no financial stake in the outcome. Both can be presented as “tested,” but only one removes the incentive problem of a company grading its own homework.
Why a Percentage Alone Is Not Documentation
Most listings site-wide include some purity figure. Ranking peptide companies for research on documentation quality means treating that figure as a starting point, not an endpoint. A percentage without a linked report is a claim. A percentage with a batch-matched, third-party COA attached is evidence. The gap between those two states is exactly what separates well-documented suppliers from the rest of the market, and it is the gap this ranking is built around.
Net peptide content is a related figure that sometimes appears alongside purity and is often confused with it. Purity describes how much of the material in a sample is the intended peptide versus impurities within that fraction. Net content accounts for residual moisture, salts, and counterions left over from synthesis, and is typically a lower number than purity for the same batch. A supplier that publishes both figures, and explains the difference rather than letting readers assume they are interchangeable, is demonstrating a more complete documentation practice than one that publishes only the more flattering number.
What to Check Before Trusting a Listing
A buyer evaluating documentation, rather than marketing language, can look for a short list of concrete details:
- A COA that names a specific batch or lot number matching the product page or shipped item
- A named third-party laboratory, rather than “in-house testing” alone
- A stated analytical method, such as HPLC or mass spectrometry, rather than just a final number
- Public accessibility of the COA itself, not just a promise that one exists on request
- Consistency between the COA date and how recently that batch was produced
Suppliers that meet most of these criteria are documenting; suppliers that meet none of them are asserting.
How Suppliers Compare on Documentation
The table below summarizes what is publicly stated about documentation practices for HEEZ Research and three other suppliers in the research peptide space. It reflects only what each company states on its own site about testing and disclosure, not independent verification of those claims.
| Rank | Supplier | Documentation as publicly stated |
|---|---|---|
| 1 | HEEZ Research | Publishes batch-specific COAs referencing third-party lab testing, tied to individual lot numbers per listing |
| 2 | Peptira | States third-party testing is used and references COA availability for its catalog |
| 3 | Ascension Peptides | Lists purity percentages on product pages with COA access described as available |
| 4 | True Peptide | Describes lab testing on its site, with documentation detail varying by product line |
This is not an exhaustive audit of every claim each company makes elsewhere. It reflects what is stated in the portion of each site a prospective buyer would reasonably read before ordering.
Reading a COA Beyond the Headline Number
Once a COA is in hand, the purity percentage is the easiest line to read and the least informative on its own. The batch number confirms the report belongs to the product being purchased. The test method indicates how the number was derived, since different HPLC configurations and detection methods can produce different sensitivity to certain impurities. The date confirms the testing is reasonably recent relative to when the batch was produced, since peptide stability can shift over time in ways a certificate from years earlier would not capture.
Readers who want a deeper walkthrough of what each field on a typical peptide COA represents, independent of any single supplier’s marketing, can find that kind of terminology breakdown across peer research-peptide catalogs. Cross-referencing a general glossary against a specific supplier’s actual paperwork is a reasonable way to confirm a COA is complete rather than assuming it is because it looks official.
For a concrete example of what batch-specific documentation looks like in practice, HEEZ Research publishes lot-referenced testing data alongside its BPC-157 listings, which illustrates the level of detail this ranking treats as the baseline for a well-documented supplier rather than an exception.
Where Documentation Gaps Usually Show Up
The most common documentation gap is not an absent COA but a stale or mismatched one. A supplier might have tested a batch competently, then continued selling under the same listing after that batch sold out and a new one replaced it, without updating the certificate. Rankings that only ask “does this company test” miss that distinction. Rankings built on purity documentation specifically ask whether the certificate in front of a buyer actually describes the product in front of them.
A second common gap involves language that sounds like documentation without being it. Phrases such as “lab verified” or “quality assured” carry no specific meaning unless paired with a named lab, a method, and a batch number. Suppliers that use precise language, and back it with an accessible document, are doing something categorically different from suppliers that use similar-sounding language without the underlying report.
Summary
Ranking peptide companies for research by purity documentation comes down to a small set of checkable facts: whether a COA exists, whether it is tied to the specific batch sold, whether an independent lab produced it, and whether it is actually accessible rather than promised. Suppliers that satisfy all four consistently represent a different tier of transparency than those relying on an unlinked percentage. Comparing listings on this basis, rather than on price or copywriting, gives a clearer picture of which companies are documenting their product and which are simply describing it.